DD156805A5 - Verfahren zur herstellen anti-hypertensiv wirkender stoffe - Google Patents

Verfahren zur herstellen anti-hypertensiv wirkender stoffe Download PDF

Info

Publication number
DD156805A5
DD156805A5 DD81228170A DD22817081A DD156805A5 DD 156805 A5 DD156805 A5 DD 156805A5 DD 81228170 A DD81228170 A DD 81228170A DD 22817081 A DD22817081 A DD 22817081A DD 156805 A5 DD156805 A5 DD 156805A5
Authority
DD
German Democratic Republic
Prior art keywords
compound
obtained according
formula
reacted
radical
Prior art date
Application number
DD81228170A
Other languages
German (de)
English (en)
Inventor
James W Ryan
Alfred Chung
Original Assignee
Univ Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Miami filed Critical Univ Miami
Publication of DD156805A5 publication Critical patent/DD156805A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C329/00Thiocarbonic acids; Halides, esters or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DD81228170A 1980-03-10 1981-03-10 Verfahren zur herstellen anti-hypertensiv wirkender stoffe DD156805A5 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12895380A 1980-03-10 1980-03-10
US15827880A 1980-06-10 1980-06-10
AU73631/81A AU7363181A (en) 1980-03-10 1981-07-31 Anti-ace peptide preparative methods

Publications (1)

Publication Number Publication Date
DD156805A5 true DD156805A5 (de) 1982-09-22

Family

ID=27156035

Family Applications (1)

Application Number Title Priority Date Filing Date
DD81228170A DD156805A5 (de) 1980-03-10 1981-03-10 Verfahren zur herstellen anti-hypertensiv wirkender stoffe

Country Status (14)

Country Link
EP (1) EP0038117A1 (da)
JP (3) JPH0667903B2 (da)
KR (1) KR850001629B1 (da)
AU (1) AU7363181A (da)
CS (1) CS174581A2 (da)
DD (1) DD156805A5 (da)
DK (1) DK105981A (da)
ES (5) ES500254A0 (da)
FI (1) FI810725L (da)
GR (1) GR74795B (da)
NO (5) NO156695C (da)
PL (1) PL230076A1 (da)
PT (1) PT72635B (da)
SU (1) SU1567125A3 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056935B2 (en) 1995-06-07 2006-06-06 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
US5801187A (en) 1996-09-25 1998-09-01 Gpi-Nil Holdings, Inc. Heterocyclic esters and amides
CN111039838B (zh) * 2019-12-31 2022-04-05 杭州乐敦科技有限公司 一种3-乙酰巯基-2-甲基丙酸的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA802420B (en) * 1979-05-18 1981-04-29 Squibb & Sons Inc Aminoacyl derivatives of mercaptoacyl amino acids

Also Published As

Publication number Publication date
DK105981A (da) 1981-09-11
PT72635B (en) 1982-03-19
NO156695B (no) 1987-07-27
JPH0667902B2 (ja) 1994-08-31
NO831113L (no) 1981-09-11
ES8305698A1 (es) 1983-04-16
FI810725L (fi) 1981-09-11
ES500254A0 (es) 1983-04-16
ES519567A0 (es) 1984-03-16
EP0038117A1 (en) 1981-10-21
NO831111L (no) 1981-09-11
PL230076A1 (da) 1982-09-13
JPH01250344A (ja) 1989-10-05
CS174581A2 (en) 1990-09-12
ES8403104A1 (es) 1984-03-01
JPH0667901B2 (ja) 1994-08-31
JPH02209865A (ja) 1990-08-21
JPH01246257A (ja) 1989-10-02
PT72635A (en) 1981-04-01
ES8403448A1 (es) 1984-03-16
ES519565A0 (es) 1984-03-16
JPH0667903B2 (ja) 1994-08-31
KR830005133A (ko) 1983-08-03
NO810795L (no) 1981-09-11
ES8403450A1 (es) 1984-03-16
ES519566A0 (es) 1984-03-16
ES8403449A1 (es) 1984-03-16
NO831112L (no) 1981-09-11
SU1567125A3 (ru) 1990-05-23
KR850001629B1 (ko) 1985-10-31
NO156695C (no) 1987-11-04
ES519564A0 (es) 1984-03-01
NO831114L (no) 1981-09-11
GR74795B (da) 1984-07-12
AU7363181A (en) 1983-02-03

Similar Documents

Publication Publication Date Title
DE69130408T2 (de) Endothelinantagonistische Peptidderivate
DE3789371T2 (de) Aryloxy- und Arylacyloxymethyl-Ketone als Thiolprotease-Hemmungsstoffe.
DE2703828C2 (de) Prolinderivate und ähnliche Verbindungen und ihre Verwendung bei der Bekämpfung von Bluthochdruck
DE3428942C2 (de) (h-pth)-peptidderivate
DE2366379C2 (de) N↑α↑-geschützte N↑G↑-Nitro-L-arginyl-L-prolin-amide
DD145749A5 (de) Verfahren zur herstellung von mercaptoacylderivaten von substituierten prolinen
DE3689508T2 (de) Peptide.
CS207578B2 (en) Method of preparation of the proline derivatives
DD201777A5 (de) Verfahren zum herstellen von neuen peptiden
DE3012140A1 (de) Mercaptoacylpeptide, verfahren zu ihrer herstellung und ihre verwendung als ace-inhibitoren und bei der behandlung von hochdruck
DE3889726T2 (de) Synthetische inhibitoren von säugetier-collagenase.
EP0029488A1 (de) Aminosäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Bluthochdruck
EP0052870A1 (de) Aminosäurederivate und Verfahren zu ihrer Herstellung
DE2632396C2 (de) Bestatin-Analoga, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
DE2730549A1 (de) Peptidderivate und deren herstellung
EP0292729A2 (de) Neue Festphasen-Peptidsynthesemethoden
DE2518160C2 (da)
DD156805A5 (de) Verfahren zur herstellen anti-hypertensiv wirkender stoffe
EP0545198B1 (de) Peptide mit insulinartiger Wirkung
DE3687702T2 (de) Schutz von methionin in einer polypeptid-kette von irreversibler oxydation.
DD206553A5 (de) Verfahren zur herstellung von tripeptiden
DE3108322A1 (de) Chromogenes enzymsubstrat
DD156706A5 (de) Herstellungsverfahren fuer einen inhibitor fuer angiotensin umwandelnder enzym
DE3222779A1 (de) Prolinderivate und verfahren zu deren herstellung
DE3202289A1 (de) Verfahren zur bestimmung der c(pfeil abwaerts)1(pfeil abwaerts)-esterase-inhibitor-aktivitaet von c(pfeil abwaerts)1(pfeil abwaerts)-esterase-inhibitor-haeltigen proben

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee